Appraisal and implications of predictive testing for insulin-dependent diabetes mellitus

Diabetes and Metabolism

Volumn 24, Issue 6, 1998, Pages 550-553

  Lucidarme, N ^a   Domingues Muriel, E ^b   Castro, D ^b   Czernichow, P ^b   Levy Marchal, C ^b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b NONE

Author keywords

Antibodies; Insulin dependent diabetes mellitus; Questionnaire; Risk; Screening

Indexed keywords

ARTICLE; BLOOD GLUCOSE MONITORING; DIAGNOSTIC VALUE; GENETIC SUSCEPTIBILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PARENTAL BEHAVIOR; PATIENT EDUCATION; QUESTIONNAIRE; RISK ASSESSMENT; SCREENING TEST; SIBLING;

CHILD; DIABETES MELLITUS, TYPE 1; EVALUATION STUDIES; HUMANS; MASS SCREENING; PREDICTIVE VALUE OF TESTS; QUESTIONNAIRES; RECURRENCE; RISK FACTORS;

EID: 0032434880     PISSN: 03381684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Deschamps I, Boitard C, Hors J, et al. Life table analysis of the risk of type I (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markers. Diabetologia, 1992, 35, 951-957.
2. Lévy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P. Islet cell antibodies in normal French schoolchildren. Diabetologia, 1992, 35, 577-582.
3. Lévy-Marchal C, Czernichow P and the French Incidence Study Group. Heterogeneity of type 1 diabetes at onset in children : results from the French incidence study. Diabete Metab, 1993, 19, 296-303.
4. Ongagna JC, Lévy-Marchal C. Sensitivity at diagnosis of combined b-cell autoantibodies in insulin-dependent diabetic children. Diabete Metab, 1997, 23, 155-160.
5. Bottazzo GF, Florin-Christiansen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiences. Lancet, 1974, ii, 1279-1283.
6. Tarn AC, Thomas JM, Dean BM, et al. Predicting insulin-dependent diabetes. Lancet, 1988, 16, 845-850.
7. Bingley PJ for the ICARUS group. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in islet cell antibody-positive relatives. Diabetes, 1996, 45, 1720-1728.
8. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes, 1996, 45, 926-933.
9. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med, 1990, 323, 1167-1172.
10. Bennett Johnson S, Riley WJ,Apperson Hansen C,Nurick MA. Psychological impact of islet cell antibody screening. Diabetes Care, 1990, 13, 93-97.
11. Bennett Johnson S, Tercyak KP. Psychological impact of islet cell antibody screening for IDDM on children, adults, and their family members. Diabetes Care, 1995, 18, 1370-1372.
12. Wagner A, Tibben A, Bruining GJ, et al. Preliminary experience with predictive testing for insulin-dependent diabetes mellitus. Lancet, 1995, 346, 380-381.
13. Wiggins S, Whyte P, Huggins M, et al. The psychological consequences of predictive testing for Huntington's disease. N Engl J Med, 1992, 327, 1402-1406.